C.129P2-Ccr5tm1Blck/Biat

Status

Available to order

EMMA IDEM:11143
Citation informationRRID:IMSR_EM:11143 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC.129P2-Ccr5tm1Blck/Biat
Alternative name5-C
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCcr5tm1Blck
Gene/Transgene symbolCcr5

Information from provider

ProviderBruno Luckow
Provider affiliationNephrologisches Zentrum, Arbeitsgruppe Klinische Biochemie, Klinikum der Universitaet Muenchen, Medizinische Klinik und Poliklinik IV
Genetic informationThe chemokine receptor Ccr5 has been inactivated by homologous recombination in ES cells. The mutant mice carry a lacZ reporter gene. They have been backcrossed to the BALB/c genetic background.
Phenotypic informationHomozygous:
Homozygous animals appear healthy and fertile and show unchallenged no obvious phenotype. Upregulated in many infectious and inflammatory diseases. Important role in leukocyte chemotaxis and innate immunity.

Heterozygous:
Unknown, but most likely wildtype phenotype
Breeding historyCurrently maintained on the BALB/cAnNCrl background, N16+F5.
References
  • Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice.;Luckow Bruno, Joergensen Joanne, Chilla Silvia, Li Jian-Ping, Henger Anna, Kiss Eva, Wieczorek Grazyna, Roth Lukas, Hartmann Nicole, Hoffmann Reinhard, Kretzler Matthias, Nelson Peter J, Pérez de Lema Guillermo, Maier Holger, Wurst Wolfgang, Balling Rudi, Pfeffer Klaus, Gröne Hermann-Josef, Schlöndorff Detlef, Zerwes Hans-Günter, ;2004;European journal of immunology;34;2568-78; 15307189
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria

Disease and phenotype information

MGI phenotypes (allele matching)
  • altered response to myocardial infarction / MGI
  • abnormal leukocyte adhesion / MGI
  • increased length of allograft survival / MGI
  • abnormal cellular extravasation / MGI
MGI phenotypes (gene matching)
  • altered response to myocardial infarction / MGI
  • abnormal locomotor behavior / MGI
  • abnormal spatial learning / MGI
  • abnormal cardiovascular system physiology / MGI
  • decreased inflammatory response / MGI
  • decreased susceptibility to viral infection / MGI
  • increased susceptibility to bacterial infection / MGI
  • abnormal CD4-positive, alpha beta T cell morphology / MGI
  • abnormal leukocyte physiology / MGI
  • abnormal conditioned taste aversion behavior / MGI
  • abnormal cytokine secretion / MGI
  • liver failure / MGI
  • increased alcohol consumption / MGI
  • abnormal leukocyte adhesion / MGI
  • nervous system phenotype / MGI
  • abnormal nervous system physiology / MGI
  • abnormal glial cell physiology / MGI
  • impaired macrophage chemotaxis / MGI
  • increased length of allograft survival / MGI
  • abnormal CD8-positive, alpha beta T cell morphology / MGI
  • decreased T cell proliferation / MGI
  • decreased susceptibility to injury / MGI
  • cardiovascular system phenotype / MGI
  • behavior/neurological phenotype / MGI
  • reproductive system phenotype / MGI
  • increased susceptibility to fungal infection / MGI
  • abnormal heart size / MGI
  • corneal vascularization / MGI
  • increased susceptibility to type IV hypersensitivity reaction / MGI
  • increased NK T cell number / MGI
  • abnormal NK T cell physiology / MGI
  • decreased NK cell number / MGI
  • abnormal Kupffer cell morphology / MGI
  • abnormal long term spatial reference memory / MGI
  • increased IgG1 level / MGI
  • decreased susceptibility to induced colitis / MGI
  • increased interferon-gamma secretion / MGI
  • decreased interleukin-1 beta secretion / MGI
  • increased interleukin-4 secretion / MGI
  • decreased interleukin-6 secretion / MGI
  • abnormal cytokine level / MGI
  • decreased susceptibility to endotoxin shock / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • abnormal astrocyte physiology / MGI
  • abnormal Ito cell morphology / MGI
  • abnormal cellular extravasation / MGI
  • abnormal hepatocyte physiology / MGI
  • decreased right ventricle systolic pressure / MGI
  • mortality/aging / MGI
  • increased fluid intake / MGI
  • decreased microglial cell activation / MGI

Literature references

  • Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice.;Luckow Bruno, Joergensen Joanne, Chilla Silvia, Li Jian-Ping, Henger Anna, Kiss Eva, Wieczorek Grazyna, Roth Lukas, Hartmann Nicole, Hoffmann Reinhard, Kretzler Matthias, Nelson Peter J, Pérez de Lema Guillermo, Maier Holger, Wurst Wolfgang, Balling Rudi, Pfeffer Klaus, Gröne Hermann-Josef, Schlöndorff Detlef, Zerwes Hans-Günter, ;2004;European journal of immunology;34;2568-78; 15307189

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).